Silverback Therapeutics Stock Market Value
| SPRY Stock | 14.29 0.03 0.21% |
| Symbol | Silverback |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Silverback Therapeutics. If investors know Silverback will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Silverback Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Silverback Therapeutics is measured differently than its book value, which is the value of Silverback that is recorded on the company's balance sheet. Investors also form their own opinion of Silverback Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Silverback Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Silverback Therapeutics' market value can be influenced by many factors that don't directly affect Silverback Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Silverback Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Silverback Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Silverback Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Silverback Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Silverback Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Silverback Therapeutics.
| 02/07/2024 |
| 02/01/2025 |
If you would invest 0.00 in Silverback Therapeutics on February 7, 2024 and sell it all today you would earn a total of 0.00 from holding Silverback Therapeutics or generate 0.0% return on investment in Silverback Therapeutics over 360 days. Silverback Therapeutics is related to or competes with Zura Bio, Annexon, In8bio, Wave Life, Palisade Bio, Allarity Therapeutics, and Windtree Therapeutics. More
Silverback Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Silverback Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Silverback Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 20.81 | |||
| Value At Risk | (6.80) | |||
| Potential Upside | 5.58 |
Silverback Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Silverback Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Silverback Therapeutics' standard deviation. In reality, there are many statistical measures that can use Silverback Therapeutics historical prices to predict the future Silverback Therapeutics' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.28) | |||
| Total Risk Alpha | (0.50) | |||
| Treynor Ratio | (0.14) |
Silverback Therapeutics Backtested Returns
Silverback Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0455, which indicates the firm had a -0.0455 % return per unit of risk over the last 3 months. Silverback Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Silverback Therapeutics' Coefficient Of Variation of (2,198), variance of 15.09, and Risk Adjusted Performance of (0.03) to confirm the risk estimate we provide. The entity has a beta of 1.35, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Silverback Therapeutics will likely underperform. At this point, Silverback Therapeutics has a negative expected return of -0.18%. Please make sure to validate Silverback Therapeutics' kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Silverback Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.11 |
Insignificant predictability
Silverback Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between Silverback Therapeutics time series from 7th of February 2024 to 5th of August 2024 and 5th of August 2024 to 1st of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Silverback Therapeutics price movement. The serial correlation of 0.11 indicates that less than 11.0% of current Silverback Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.11 | |
| Spearman Rank Test | 0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 2.93 |
Silverback Therapeutics lagged returns against current returns
Autocorrelation, which is Silverback Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Silverback Therapeutics' stock expected returns. We can calculate the autocorrelation of Silverback Therapeutics returns to help us make a trade decision. For example, suppose you find that Silverback Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Silverback Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Silverback Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Silverback Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Silverback Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Silverback Therapeutics Lagged Returns
When evaluating Silverback Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Silverback Therapeutics stock have on its future price. Silverback Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Silverback Therapeutics autocorrelation shows the relationship between Silverback Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Silverback Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Silverback Stock Analysis
When running Silverback Therapeutics' price analysis, check to measure Silverback Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Silverback Therapeutics is operating at the current time. Most of Silverback Therapeutics' value examination focuses on studying past and present price action to predict the probability of Silverback Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Silverback Therapeutics' price. Additionally, you may evaluate how the addition of Silverback Therapeutics to your portfolios can decrease your overall portfolio volatility.